Biolinerx Ltd.
13F holders, Q3 2024 (September 30)32holders +1
5new positions
3sold out
$0.54avg. 13F price*
At the end of Q3 2024, 32 institutions reported holding Biolinerx Ltd. in their 13F filings, up 1 from Q2 2024. 5 opened new positions and 3 sold out. The largest holders were Alyeska Investment Group, L.P. ($465K), Envestnet Asset Management Inc. ($128K) and Morgan Stanley ($106K).
- Company
- Biolinerx Ltd.
- CUSIP
- 09071M205
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $54K |
| Exits | 3 | $26K |
All 13F filers, Q2 2024 → Q3 2024: 360,850 shares bought and 1,302,269 shares sold, net −941,419 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Alyeska Investment Group, L.P. | 0.00% | Reduce -55.6% | 866,495 | $465K |
| Envestnet Asset Management Inc. | 0.00% | Add +11.9% | 239,186 | $128K |
| Morgan Stanley | 0.00% | Add +188.6% | 197,537 | $106K |
| Values First Advisors, Inc. | 0.06% | Reduce -3.1% | 197,516 | $106K |
| PVG Asset Management Corp. | 0.34% | Add +27.2% | 157,215 | $84K |
| Atria Investments, Inc | 0.00% | Add +27.9% | 133,974 | $72K |
| Atria Wealth Solutions, Inc. | 0.00% | Reduce -5.2% | 94,133 | $50K |
| LPL Financial LLC | 0.00% | Add +12.2% | 92,000 | $49K |
| Cetera Investment Advisers | 0.00% | Add +11.8% | 80,158 | $43K |
| XTX Topco Ltd | 0.00% | New | 44,135 | $24K |
| Orin Green Financial, LLC | 0.01% | No change | 43,000 | $23K |
| Geode Capital Management, LLC | 0.00% | No change | 39,993 | $21K |
| Rathbones Group PLC | 0.00% | No change | 39,820 | $21K |
| Wells Fargo & Company | 0.00% | Reduce -37.5% | 35,035 | $19K |
| Rhumbline Advisers | 0.00% | Add +26.7% | 32,611 | $17K |
| Gradient Investments LLC | 0.00% | No change | 30,000 | $16K |
| Weaver Consulting Group | 0.01% | Add +75.8% | 29,745 | $16K |
| Nemes Rush Group LLC | 0.00% | No change | 12,000 | $13K |
| Virtu Financial LLC | 0.00% | New | 21,326 | $11K |
| Susquehanna International Group, LLP | 0.00% | Reduce -84.7% | 18,032 | $10K |
| Cutter & CO Brokerage, Inc. | 0.00% | No change | 16,667 | $9K |
| Captrust Financial Advisors | 0.00% | New | 16,172 | $9K |
| Qube Research & Technologies Ltd | 0.00% | No change | 13,035 | $7K |
| Creative Planning | 0.00% | Reduce -0.8% | 12,982 | $7K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 10,500 | $6K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 13,250 | $5K |
| Geneos Wealth Management Inc. | 0.00% | Reduce -88.3% | 4,500 | $2K |
| NewEdge Advisors, LLC | 0.00% | No change | 4,300 | $2K |
| Osaic Holdings, Inc. | 0.00% | Reduce -14.2% | 1,206 | $646 |
| UBS Group AG | 0.00% | Reduce -33.5% | 984 | $527 |
| Tradewinds Capital Management, LLC | 0.00% | No change | 200 | $108 |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.9% | 1 | $1 |
"% of holder's portfolio" is BIOLINERX LTD's weight in each manager's 13F, not the share of Biolinerx Ltd. the manager owns.